H. Sinan Süzen

886 total citations
52 papers, 649 citations indexed

About

H. Sinan Süzen is a scholar working on Molecular Biology, Health, Toxicology and Mutagenesis and Psychiatry and Mental health. According to data from OpenAlex, H. Sinan Süzen has authored 52 papers receiving a total of 649 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 9 papers in Health, Toxicology and Mutagenesis and 8 papers in Psychiatry and Mental health. Recurrent topics in H. Sinan Süzen's work include Glutathione Transferases and Polymorphisms (8 papers), Pharmacogenetics and Drug Metabolism (7 papers) and Carcinogens and Genotoxicity Assessment (7 papers). H. Sinan Süzen is often cited by papers focused on Glutathione Transferases and Polymorphisms (8 papers), Pharmacogenetics and Drug Metabolism (7 papers) and Carcinogens and Genotoxicity Assessment (7 papers). H. Sinan Süzen collaborates with scholars based in Türkiye, United Kingdom and Cyprus. H. Sinan Süzen's co-authors include Yalçın Duydu, Asuman Karakaya, Ahmet Aydın, Mümtaz İşcan, Bora Başkak, Gareth Jenkins, James M. Parry, Simon James, Zakaria Eltahir and J N Baxter and has published in prestigious journals such as Molecules, Carcinogenesis and Toxicology and Applied Pharmacology.

In The Last Decade

H. Sinan Süzen

48 papers receiving 624 citations

Peers

H. Sinan Süzen

HTM

PHARM

SURGE

Dana Hoffmann United States

Purushothaman Meerarani United States

Yiguan Zhang China

Weipan Xu China

Lucie Stejskalová Czechia

Aziz Karaoğlu Türkiye

Yumi Hayashi Japan

Simon W. Walker United Kingdom

Sainath R. Kotha United States

Melek Öztürk Türkiye

Dana Hoffmann United States

H. Sinan Süzen

302 ×1.4

79 ×0.6

HTM

151 ×1.4

44 ×0.6

PHARM

87 ×1.2

SURGE

Citations per year, relative to H. Sinan Süzen H. Sinan Süzen (= 1×) peers Dana Hoffmann

Countries citing papers authored by H. Sinan Süzen

Since Specialization

Citations

This map shows the geographic impact of H. Sinan Süzen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Sinan Süzen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Sinan Süzen more than expected).

Fields of papers citing papers by H. Sinan Süzen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Sinan Süzen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Sinan Süzen. The network helps show where H. Sinan Süzen may publish in the future.

Co-authorship network of co-authors of H. Sinan Süzen

This figure shows the co-authorship network connecting the top 25 collaborators of H. Sinan Süzen. A scholar is included among the top collaborators of H. Sinan Süzen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Sinan Süzen. H. Sinan Süzen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Irham, Lalu Muhammad, et al.. (2025). The Role of Hydroxychloroquine in the Management of Rheumatic Disorders: A Comprehensive Review. Basic & Clinical Pharmacology & Toxicology. 137(2). e70082–e70082.

Süzen, H. Sinan, et al.. (2025). Development of HPLC methodology for quantification of naltrexone and 6β-naltrexol in human plasma and its potential in alcohol use disorder treatment monitoring. Journal of Pharmaceutical and Biomedical Analysis. 263. 116944–116944.

Özkan-Kotiloğlu, Selin, et al.. (2025). Development of a sample preparation and analysis method for therapeutic monitoring of diazepam and major metabolite in alcohol withdrawal syndrome treatment. Journal of Pharmaceutical and Biomedical Analysis. 260. 116805–116805. 1 indexed citations

Süzen, H. Sinan, et al.. (2024). An overview on Sjögren’s syndrome and systemic lupus erythematosus’ genetics. Toxicology Research. 14(1). tfae194–tfae194. 1 indexed citations

Yenıay, Levent, Yiğit Özer Tiftikçioğlu, Osman Zekioğlu, et al.. (2024). Blood and tissue levels of persistent organic pollutants and genetic susceptibility in patients with breast cancer. Environmental Toxicology and Pharmacology. 108. 104433–104433. 3 indexed citations

Süzen, H. Sinan, et al.. (2023). Evaluation of distal tibial epiphysis and calcaneal epiphysis according to the Vieth method in 3.0 T magnetic resonance images: a pilot study. International Journal of Legal Medicine. 137(4). 1181–1191. 4 indexed citations

Süzen, H. Sinan, et al.. (2020). The role of COMT polymorphism in modulation of prefrontal activity during verbal fluency in bipolar disorder. Neuroscience Letters. 738. 135310–135310. 3 indexed citations

Başkak, Bora, et al.. (2019). Association between serotonin 2A receptor (HTR2A), serotonin transporter (SLC6A4) and brain-derived neurotrophic factor (BDNF) gene polymorphisms and citalopram/sertraline induced sexual dysfunction in MDD patients. The Pharmacogenomics Journal. 20(3). 443–450. 17 indexed citations

Başkak, Bora, et al.. (2016). Influence of CYP2B6 and CYP2C19 polymorphisms on sertraline metabolism in major depression patients. International Journal of Clinical Pharmacy. 38(2). 388–394. 32 indexed citations

10.

Başkak, Bora, et al.. (2015). The impact ofCYP2C19polymorphisms on citalopram metabolism in patients with major depressive disorder. Journal of Clinical Pharmacy and Therapeutics. 40(6). 672–679. 15 indexed citations

11.

Altuner, Durdu, et al.. (2011). Are PON1 Q/R 192 and M/L 55 polymorphisms risk factors for diabetes complications in Turkish population?. Clinical Biochemistry. 44(5-6). 372–376. 21 indexed citations

12.

Süzen, H. Sinan, et al.. (2010). CYP and GST polymorphisms and survival in advanced non-small cell lung cancer patients. Neoplasma. 57(6). 512–521. 34 indexed citations

13.

Süzen, H. Sinan, et al.. (2008). Association of cytokine gene polymorphisms in CWP and its severity in Turkish coal workers. American Journal of Industrial Medicine. 51(10). 741–747. 19 indexed citations

14.

Süzen, H. Sinan, et al.. (2006). Biological Monitoring of Environmental Exposure to Polycyclic Aromatic Hydrocarbons: 1-Hydroxypyrene in Urine of Turkish Coke Oven Workers. Bulletin of Environmental Contamination and Toxicology. 76(4). 559–565. 7 indexed citations

15.

Duydu, Yalçın, et al.. (2005). Evaluation of Increased Proportion of Cells with Unusually High Sister Chromatid Exchange Counts as a Cytogenetic Biomarker for Lead Exposure. Biological Trace Element Research. 104(2). 121–130. 6 indexed citations

16.

Süzen, H. Sinan, et al.. (2005). TYMS and DPYD polymorphisms in a Turkish population. European Journal of Clinical Pharmacology. 61(12). 881–885. 23 indexed citations

17.

Süzen, H. Sinan, et al.. (2004). The oxidative DNA base damage in testes of rats after intraperitoneal cadmium injection. BioMetals. 17(4). 371–377. 52 indexed citations

18.

Süzen, H. Sinan, Yalçın Duydu, & Ahmet Aydın. (2004). Molecular Analysis of δ-Aminolevulinic Acid Dehydratase (ALAD) Gene Polymorphism in a Turkish Population. Biochemical Genetics. 42(11-12). 461–467. 10 indexed citations

19.

Süzen, H. Sinan, et al.. (2003). Influence of the delta‐aminolevulinic acid dehydratase (ALAD) polymorphism on biomarkers of lead exposure in Turkish storage battery manufacturing workers. American Journal of Industrial Medicine. 43(2). 165–171. 39 indexed citations

20.

Duydu, Yalçın, et al.. (1998). Urinary Excretion of Total and Inorganic Lead in Tetraethyllead Exposed Workers. Bulletin of Environmental Contamination and Toxicology. 60(3). 395–401. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact